I'd like to send this parcel to http://fittor.fun/promoxnxx/ readwapin Cubist, known for its Cubicin antibiotic, will also gainTrius's experimental drug, tedizolid phosphate, that showedpromise in treating skin infections in two late-stage studiesand which Cubist hopes to launch in late 2014.